Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - GROSS PROFIT
Gross Profit YMAB - Y-mAbs Therapeutics, Inc.
73.4 M
LAST VALUE
50.56%
2 YEAR CAGR
379.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR